Ottawa, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The global generic pharmaceuticals contract manufacturing market size is calculated at USD 85.99 billion in 2026 and is expected to reach around USD 143.22 ...

Teva Pharmaceuticals said it will shrink some of its generic drug manufacturing as the Israel-based drugmaker reports $20.7 billion in debt. In 2022, Teva lost revenue on generics, and the company ...

Dozens of companies have pledged to build more manufacturing in the U.S. since President Trump took office. Generic drugmakers aren’t among them. And they have no plans to change that anytime soon.

While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily toward branded drugmakers, generic medicines and the companies that ...

With Big Pharma pressing the limits in promoting and pricing prescription medications, patients and their advocates long have hoped that generic drugs might be difference-makers on costs and practices ...